A global CRO and scientific partner advancing drug development.
Our impact extends beyond trials, shaping healthier futures worldwide.
A collaborative, science-driven approach.
Recognized for excellence across the industry.
Decades of clinical and scientific leadership.
A global clinical research leader with an award-winning culture.
A culture that empowers growth, innovation, and impact.
Explore career opportunities at Novotech.
Benefits and recognition that support your success.
Experts collaborating to advance clinical research.
A commitment to your growth and development.
Start your career in clinical research with Novotech.
核心试验
2010年6月21日
内部消息——亚洲试验增长带来发展阻碍
总部位于澳大利亚合同研究组织（CRO）Novotech的首席执行官表示，尽管亚洲的临床试验活动快速增长，但申办方和CRO需要注意应对不熟悉的环境。
Alek Safarian上周在华盛顿特区举行的第46届药物信息协会（DIA）年会上表示，监管流程复杂意味着试验数量、试验患者数量和试验时间正在快速增长或增加。Mr Safarian表示，1999-2006年，临床试验的平均时间增加了近70%。作者：Simone du Toit
